First, do no harm: Confronting the myths of psychiatric drugs

Nursing Ethics

Volumn 19, Issue 4, 2012, Pages 451-463

  Barker, Phil ^a   Buchanan Barker, Poppy ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b Clan Unity International ^*  (United Kingdom)

Author keywords

Ethics; mental health nursing; power; psychiatric drugs; recovery

Indexed keywords

PSYCHOTROPIC AGENT;

ARTICLE; ETHICS; HUMAN; MENTAL DISEASE; NURSING; PSYCHIATRIC NURSING; TREATMENT OUTCOME;

HUMANS; MENTAL DISORDERS; PSYCHIATRIC NURSING; PSYCHOTROPIC DRUGS; TREATMENT OUTCOME;

EID: 84863196391     PISSN: 09697330     EISSN: 14770989     Source Type: Journal    
DOI: 10.1177/0969733011429017     Document Type: Article

References (71)

1. Whitaker RMad in America: bad science, bad medicine and the enduring mistreatment of the mentally ill. New York: Basic Books; 2001:.
2. Ryan D,Higgins AMental health ethics: the human context. Barker P, ed. London: Routledge; 2011:ch.
3. Davidson RMental health ethics: the human context. Barker P, ed. London: Routledge; 2011:ch.
4. Warne T,Keeling J,McAndrew SMental health ethics: the human context. Barker P, ed. London: Routledge; 2011:.
5. Hazelton M,Morrall PPsychiatric and mental health nursing: the craft of caring. Barker P, ed. London: Hodder Arnold; 2008:ch.
6. Barker PMental health ethics: the human context. London: Routledge; 2011:.
7. Barker P,Davidson BPsychiatric nursing: ethical strife. London: Arnold; 1998:.
8. Parsons S,Barker PJ,Armstrong A.The teaching of health care ethics to students of nursing in the UK: a pilot study.Nurs Ethics. 2001;8 (1): 45-56.
9. Barker P,Buchanan-Barker P.The myth of mental health nursing and the challenge of recovery.Int J Ment Health Nurs. 2011;20:337-344.
10. Hazelton M,Morrall PPsychiatric and mental health nursing: the craft of caring. Barker P, ed. London: Hodder Arnold; 2008:ch.
11. Szasz TSThe myth of mental illness: foundations of a theory of personal conduct. New York: Paul B Hoeber; 1961:.
12. Foucault MMadness and civilization: a history of insanity in the age of reason. New York: Random House; 1965:.
13. Barker P,Stevenson CThe construction of power and authority in psychiatry. Oxford: Butterworth-Heinemann; 1999:.
14. Double DCritical psychiatry: the limits of madness. London: Palgrave Macmillan; 2006:.
15. Moncrieff JThe myth of the chemical cure: a critique of psychiatric rug treatment. London: Palgrave Macmillan; 2009:.
16. Barker P,Buchanan-Barker P.The convenient myth of Thomas Szasz.Journal of Psychiatric and Mental Health Nursing. 2009;16:87-95.
17. Barker PMental health ethics: the human context. Barker P, ed. London: Routledge; 2011:ch.
18. Snowden APrescribing and mental health nursing. London: Quay Books; 2008:.
19. National Alliance on Mental Illness (NAMI). http://www.nami.org/(2011, accessed August 2011).
20. Barker P,Keady J,Croom S,Stevenson C,Adams T,Reynolds B.The concept of serious mental illness: modern myths and grim realities.Journal of Psychiatric and Mental Health Nursing. 1998;5 (4): 247-254.
21. Miller H.The common cold of psychiatry. Book review.British Medical Journal. 1969;31 (May): 563.
22. Barker PMental health ethics: the human context. Barker P, ed. London: Routledge; 2011:ch.
23. Patterson BMental health ethics: the human context. Barker P, ed. London: Routledge; 2011:ch.
24. Schaler JASzasz under fire: the psychiatric abolitionist faces his critics. Chicago, IL: Open Court; 2004:.
25. Huxley ABrave new world. London: Vintage; 2007:.
26. Cutcliffe J,Lakeman R.Challenging normative orthodoxies in depression: Huxley's utopia or Dante's inferno?.Archives of Psychiatric Nursing. 2010;24 (2): 114-124.
27. Mutsatsa SMedicines management in mental health nursing. Exeter: Learning Matters; 2011:.
28. James A.My tutor said to me, this talk is dangerous.The Times Higher Education Supplement. 2006;21 (April):.
29. Goldacre BBad science. London: Fourth Estate; 2008:.
30. Goldacre B.Drug firms hiding negative research are unfit to experiment on people.Guardian. 2010;14 (August):.
31. Breggin PBrain-disabling treatments in psychiatry. 2008.New York: Springer; 2008:.
32. Whitaker RAnatomy of an epidemic: magic bullets, psychiatric drugs, and the astonishing rise of mental illness in America. New York: Crown; 2010:.
33. Schatzberg AF,Cole JO,Debattista AManual of clinical psychopharmacology. 2010.Arlington, VA: American Psychiatric Publishing; 2010:.
34. Ho BC,Andreasen NC,Ziebell S,Pierson R,Magnotta V.Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.Arch Gen Psychiatry. 2011;68 (2): 128-137.
35. Cunningham-Owens DGA guide to the extra-pyramidal effects of antipsychotic drugs. Cambridge: Cambridge University Press; 1999:.
36. Hyman SE,Nestler EJ.Initiation and adaptation: a paradigm for understanding psychotropic drug action.American Journal of Psychiatry. 1996;153:151-156.
37. Moncrieff J.Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse. Acta Psychiatr Scand. 2006;114 (1): 3-13.
38. Healy D,Harris M,Michael P,Cattel D,Savage M,Chalasani P,Hirst D.Service utilization in 1896 and 1996: morbidity and mortality data from North Wales.History of Psychiatry. 2005;16 ((1)): 27 41.
39. Higgins A,Barker P,Begley C.Iatrogenic sexual dysfunction and the protective withholding of information: in whose best interest?.Journal of Psychiatric and Mental Health Nursing. 2006;13 (4): 437-446.
40. Breeze J.Can paternalism be justified in mental health care.Journal of Advanced Nursing. 1998;28 (2): 260-265.
41. Szasz TSCruel Compassion: Psychiatric Control of Society's Unwanted. Syracuse, NY: Syracuse University Press; 1998:.
42. Valenstein EBlaming the brain: the truth about drugs and mental health. New York: Free Press; 1998:.
43. BarkerPBuchanan-BarkerP. The rise in bipolar disorder is a myth. http://www.psychminded.co.uk/news/news2011/feb11/rise-in-bipolar-disorder-is-a-myth002.html(2001, accessed August 2011).
44. Barker P,Buchanan-Barker P.The tidal model of mental health recovery and reclamation: application in acute care settings.Issues in Mental Health Nursing. 2010;31:171-180.
45. Gronfein W.Psychotropic drugs and the origins of deinstitutionalisation.Social Problems. 1985;32 (5): 437-454.
46. Jablensky A,Sartorius N,Ernberg G,Anker M, et al.Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study.Psychological Medicine. 1992; ((suppl.)): 1-95.
47. Mosher L,Hendrix V,Fort DCSoteria: through madness to deliverance. Bloomington, IN: Xlibris; 2004:.
48. Alanen YOSchizophrenia - its origins and need-adapted treatment. London: Karnac; 1997:.
49. Seikkula J,Aaltonen J,Alakare B,Haarakangas K,Keränen J,Lehtinen K.Five-year experience of first-episode nonaffective psychosis in open-dialogue approach: treatment principles, follow-up outcomes, and two case studies.Psychotherapy Research. 2006;16 (2): 214-228.
50. Harding C,Brooks CW,Ashikaga T,Strauss JS,Breier A.The Vermont longitudinal study of persons with severe mental illness: II: long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia.American Journal of Psychiatry. 1987;144:727-735.
51. Harrow M,Jobe TH.Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15 year multi-follow-up study.Journal of Nervous and Mental Disease. 2007;195 (5): 406-414.
52. Als-Nielsen B,Chen W,Gluud C,Kjaergaard LL.Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?.JAMA. 2003;290:921-928.
53. Perlis RH,Perlis CS,Wu Y, et al.Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry.Am J Psychiatry. 2005;162:1957-1960.
54. Carlatt DThe trouble with psychiatry: a doctor's revelations about a profession in crisis. New York: Free Press; 2010:.
55. Lakeman R.Mental health nursing is not for sale: rethinking nursing's relationship with the pharmaceutical industry.Journal of Psychiatric and Mental Health Nursing. 2010;17 (2): 172-177.
56. Anderson KH,Ford S,Robson D,Cassis J,Rodrigues C,Gray R.An exploratory, randomized controlled trial of adherence therapy for people with schizophrenia.International Journal of Mental Health Nursing. 2010;19:340-349.
57. Lakeman R.Misplaced epistemological certainty and pharmaco-centrism in mental health nursing.Journal of Psychiatric and Mental Health Nursing. 2009;16 (2): 199-205.
58. Vuckovich P.Compliance versus adherence in serious and persistent mental illness.Nursing Ethics. 2010;17 (12): 77-85.
59. Olsen DP.Policy implications of the biological model of mental disorder.Nursing Ethics. 2000;7 (5): 412-424.
60. Harris G.Drug makers are advocacy groups biggest donors.New York Times. 2009;22 (October): A23.
61. Mosher L,Gosden R,Beder SModel of madness. Read JMosher L andBentall R, ed. London: Routledge; 2004:115-130.
62. Jutel A,Menkes DB.Soft targets: Nurses and the pharmaceutical industry.PLoS Medicine. 2008;5 (2): e5.
63. Crock E.Ethics of pharmaceutical company relationships with the nursing profession: no free lunch...and no more pens?.Contemp Nurse. 2009;33 (2): 202-209.
64. Olsen DP.Nurses and the pharmaceutical industry.American Journal of Nursing. 2009;109 (2): 86-87.
65. Jones ESigmund Freud: life and work. London: Hogarth Press; 1953:94-96.
66. Szasz TSPsychiatry: the science of lies. Syracuse, NY: Syracuse University Press; 2008:.
67. Barker P.The virtue of caring.International Journal of Nursing Studies. 2000;37:329-336.
68. Tschudin VEthics in nursing: the caring relationship. 2003.Edinburgh: Butterworth-Heinemann; 2003:.
69. Smith CM.Origin and uses of 'Primum Non Nocere' - above all, do no harm.J Clin Pharm. 2005;45 (4): 371-377.
70. Cutcliffe JR.Has the die been cast? Rediscovering the essence of psychiatric/mental health nursing.British Journal of Nursing. 2008;17 (2): 88-92.
71. Higgins A.Mental health nurses have vital role.The Irish Examiner. 2011;23 (September):.